Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 312,012 | 125,297 | 127,598 | 126,003 | 98,165 |
| Marketable Securities | 588,753 | 265,593 | 110,250 | 119,658 | 188,912 |
| TOTAL | $910,355 | $397,244 | $245,008 | $252,884 | $296,472 |
| Non-Current Assets | |||||
| PPE Net | 5,457 | 5,274 | 5,850 | 6,453 | 6,467 |
| Other Non-Current Assets | 21,795 | 23,415 | 23,959 | 24,461 | 24,959 |
| TOTAL | $27,252 | $28,689 | $29,809 | $30,914 | $31,426 |
| Total Assets | $937,607 | $425,933 | $274,817 | $283,798 | $327,898 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,504 | 16,029 | 16,625 | 14,154 | 12,013 |
| Accrued Expenses | 52,902 | 44,511 | 40,139 | 33,553 | 42,132 |
| TOTAL | $63,953 | $62,246 | $58,422 | $49,318 | $55,710 |
| Non-Current Liabilities | |||||
| Long Term Debt | 222,895 | 44,250 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 14,388 | 16,973 | 17,410 | 15,485 | 15,902 |
| TOTAL | $237,283 | $61,223 | $61,359 | $15,485 | $15,902 |
| Total Liabilities | $301,236 | $123,469 | $119,781 | $64,803 | $71,612 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 162,309 | 142,377 | 139,701 | 113,857 | 113,850 |
| Common Shares | 161 | 141 | 114 | 114 | 110 |
| Retained earnings | -1,188,420 | -1,085,928 | -1,004,998 | -931,469 | -859,483 |
| Other shareholders' equity | 89,748 | 108,123 | 107,928 | 108,329 | 111,047 |
| TOTAL | $636,371 | $302,464 | $155,036 | $218,995 | $256,286 |
| Total Liabilities And Equity | $937,607 | $425,933 | $274,817 | $283,798 | $327,898 |